Chiome Bioscience Inc.JP:4583

Market cap

¥7.5B

P/E ratio

	2014/03	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	5,418	1,301	4,553	4,027	2,329	2,106	2,686	1,791	1,727	1,326	2,063
Marketable securities, current	-	-	2,799	-	-	-	-	-	-	-	-	-
Total current assets	-	5,574	4,274	4,682	4,197	2,610	2,561	3,249	2,217	2,092	1,629	2,338
Property, plant and equipment, net	-	396	436	35	23	16	11	7	4	2	1	-
Marketable securities, non-current	-	-	114	-	150	150	150	150	-	-	-	-
Total non-current assets	-	537	645	108	223	221	247	246	123	123	122	131
Total assets	-	6,111	4,919	4,789	4,419	2,831	2,808	3,495	2,339	2,215	1,751	2,469
Short-term debt	-	-	-	-	-	-	-	180	183	184	291	282
Long-term debt, current	-	-	46	50	4	-	-	-	-	-	-	-
Total current liabilities	-	233	238	169	161	113	145	343	393	370	539	493
Long-term debt, non-current	-	-	54	4	-	-	-	-	-	-	-	-
Total non-current liabilities	-	63	117	55	41	41	41	42	54	54	55	55
Total liabilities	-	296	355	224	202	154	187	385	446	425	594	549
Common stock and paid-in capital	-	8,859	8,881	10,363	10,900	10,900	12,254	4,375	4,632	5,794	6,377	2,931
Retained earnings	-	-3,061	-4,344	-5,835	-6,717	-8,251	-9,655	-1,294	-2,774	-4,016	-5,236	-1,021
Stockholders' equity	4,525	5,815	4,564	4,565	4,218	2,677	2,622	3,110	1,893	1,791	1,158	1,920